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■ CASE REPORT ■
Introduction
Uterine artery embolization (UAE) is a minimally inva-
sive therapy for uterine leiomyoma according to the
American College of Obstetricians and Gynecologists
committee. Although UAE for women who want to
retain their fertility remains investigational or relatively
contraindicated [1], there have been only a few reports
of pregnancies after UAE. The risks for pregnancy fol-
lowing UAE remain unknown. We report here a case of
placenta accreta following UAE for uterine leiomyoma.
Case Report
The patient was a 30-year-old primigravida woman. She
had undergone UAE for interstitial uterine leiomyoma in
the anterior wall. The myoma was reduced in volume by
22% after treatment. She then conceived 2 years after
the treatment. The placenta was located on the calcified
rim around the leiomyoma, which had a diameter of 
4 cm. The patient was admitted to hospital for prema-
ture rupture of the membranes at 34 weeks of gestation.
After onset of labor, she normally delivered a vigorous
female infant weighing 1,950 g at 34 weeks and 2 days of
gestation. The placenta was retained despite traction on
the cord. We removed the placenta manually owing to
increasing postpartum hemorrhage. However, the bleed-
ing continued after removal. The patient entered a state
of hypovolemic shock, and we performed emergency
supracervical hysterectomy. Total blood loss was more
than 5 L, and 24 units of packed red cells and 18 units of
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fresh frozen plasma were transfused. The postoperative
course was uneventful, and the patient left the hospital
10 days later. Placenta accreta was confirmed histologi-
cally, although the finding was unclear macroscopically
(Figure). The uterine leiomyoma showed low cellular
components with calcification and degeneration.
Discussion
UAE is currently a common treatment for uterine leiomy-
oma. It was first reported by Ravina et al [2] in 1995.
There have been several reports of pregnancies follow-
ing UAE. Goldberg et al [3] reviewed cases of preg-
nancy following UAE and concluded that there were
risks for malpresentation, preterm birth, cesarean deliv-
ery, and postpartum hemorrhage. Two cases of pla-
centa accreta following UAE have been reported. Pron
et al [4] reported one case among 18 pregnancies fol-
lowing UAE. The patient was a 34-year-old primigravida
woman. A cesarean section was performed because of
secondary arrest at 41 weeks’ gestation. Cesarean hys-
terectomy was performed owing to prolonged retained
placenta. Histologic findings showed placenta accreta.
El-Miligy et al [5] also recently reported a case of par-
tial placental accreta, which, however, was not proven
histologically.
Abnormal placental adherence usually occurs in
patients with a history of uterine surgery or placenta
previa. The placental position in our case was normal,
and the only past history was UAE. Therefore, we spec-
ulate that the UAE was associated with placenta accreta.
In addition, the implantation site was just on the leiomy-
oma with degeneration and calcification. Peripheral
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Figure. The villi are implanted directly on the myometrium of
the uterine wall.
calcification of a leiomyoma is observed 6 months
after UAE and is believed to be the end stage of hyaline
degeneration. When the reduction rate is more than
50%, a peripheral hyperechoic rim around the leiomyoma
can form [6]. The reduction rate in our case was 78%,
and we observed a calcified rim. UAE had a positive
effect on leiomyoma reduction in our case.
Effective UAE indicates “strict” embolization. Path-
ologic features after UAE in some cases include foci of
myometrial necrosis beyond the confines of the leiomy-
omas [7]. The endometrium around the leiomyoma may
have a tendency to result in necrosis from effective UAE.
The mechanism of placenta accreta in our case might
have been the result of infarction of the uterine endo-
metrium following UAE, which led to deficiency of the
decidua basalis and resulted in abnormal trophoblast
invasion into the myometrium.
Despite the American College of Obstetricians and
Gynecologists committee opinion [1], the number of
pregnancies after UAE may increase in the near future as
UAE becomes a common treatment for leiomyoma. The
possibility of placenta accreta should be considered in
pregnancy after UAE, especially when the implantation
site is on a calcified rim around leiomyoma, where the
risk may be much higher.
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